The blood-oxygen feature of the Apple Watch Series 9 and Ultra 2 models is scheduled to be removed by Apple. With the blood-oxygen feature’s popularity and promotion as a vital health-related featur.its removal is a major step.In the event that an appeal of the ruling is unsuccessful, Apple Inc. intends to take the blood-oxygen feature out of its most recent smartwatches, the Series 9 and Ultra 2, in order to circumvent a US ban on the devices.
Masimo Corp., which has been embroiled in a legal dispute with Apple over patents pertaining to the technology, revealed the plan on Monday. It stated that the action was approved on January 12 by US Customs and Border Protection. The agency “decided that Apple’s redesign falls outside the scope” of an import ban by the US International Trade Commission, signaling that the adjustment will let Apple keep its watches on the market.
In October, the ITC declared that Apple’s products infringed upon Masimo’s blood-oxygen measurement patents. Due to this, Apple decided to halt sales of the smartwatches just in time for Christmas. However, the company was able to resume sales of the devices late last month after an interim suspension.
The manufacturer of iPhones created a software workaround to get around the disagreement and last week gave the customs agency—which is in charge of enforcing import bans—the solution. According to Masimo, Apple clarified that the updated watches “definitively” do not include the problematic pulse oximetry technology.
The dramatic move would most likely only happen in the event that Apple is unable to convince a federal appeals court to grant a longer stay. The US Court of Appeals for the Federal Circuit is expected to rule on the company’s request for a stay of proceedings for the duration of the appeal as early as Tuesday, the company said on Monday. The business stated that it thinks the phase might extend to a year or longer.
According to the Cupertino, California-based company, the blood-oxygen feature of the Apple Watch is still accessible on freshly sold devices until that time. Although it has been shared with the parties, the customs agency has not made its decision publicly available.
Masimo stated, “Apple’s assertion that its updated watch does not have pulse oximetry is a positive step towards accountability.” “It is crucial that one of the biggest and most influential corporations in the world upholds the intellectual property rights of smaller businesses and obeys ITC orders when it is discovered to be infringing.”
It would be a big step to remove the Apple Watch’s technology. The blood-oxygen app and its algorithms have been altered by the company’s engineers in a software update that aims to work around the problem without removing the feature. However, getting rid of the feature would probably be the quickest way to prevent the ban from being reinstated, which could have happened as soon as this month.
Apple might have had to pay a high price to avoid a US import ban, according to a note from Bloomberg Intelligence analyst Tamlin Bason. It was a much-lauded feature.
While it’s a good thing to address the immediate risk of a ban, Bason stated that the action “could dent customer demand.”
In the unlikely event that the appeal is denied this week, Apple’s operations team has already started shipping customised Series 9 and Ultra 2 watches to US retail locations. The stores were instructed not to open or begin selling the modified devices until they had confirmation from Apple’s corporate headquarters. Those models might be the updated models that don’t have the blood-oxygen feature.
In a related development, Apple is anticipated to present its case for a prolonged stay on the ban to a federal appeals court as soon as this week. In the interim, the ban was temporarily lifted while Apple awaits a hearing. The trade commission requested last week that an appeals court disregard the “weak and unconvincing” arguments put forth in favour of an attempt to stop the trade agency from enforcing the ban.
